94 related articles for article (PubMed ID: 17260012)
1. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterisation of acral melanoma cell lines.
Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
[TBL] [Abstract][Full Text] [Related]
4. Can different genetic changes characterize histogenetic subtypes and biologic behavior in sporadic malignant melanoma of the skin?
Poetsch M; Dittberner T; Woenckhaus C
Cell Mol Life Sci; 2003 Sep; 60(9):1923-32. PubMed ID: 14523552
[TBL] [Abstract][Full Text] [Related]
5. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
6. Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
Heidenblad M; Lindgren D; Jonson T; Liedberg F; Veerla S; Chebil G; Gudjonsson S; Borg A; Månsson W; Höglund M
BMC Med Genomics; 2008 Jan; 1():3. PubMed ID: 18237450
[TBL] [Abstract][Full Text] [Related]
7. Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targets.
Lukáčová E; Pös O; Túryová E; Hurtová T; Hanzlíková Z; Szemes T; Burjanivová T
Neoplasma; 2024 Apr; 71(2):143-152. PubMed ID: 38766854
[TBL] [Abstract][Full Text] [Related]
8. Tracing cancer evolution and heterogeneity using Hi-C.
Erdmann-Pham DD; Batra SS; Turkalo TK; Durbin J; Blanchette M; Yeh I; Shain H; Bastian BC; Song YS; Rokhsar DS; Hockemeyer D
Nat Commun; 2023 Nov; 14(1):7111. PubMed ID: 37932252
[TBL] [Abstract][Full Text] [Related]
9. Signatures of mutation and selection in the cancer genome.
Bignell GR; Greenman CD; Davies H; Butler AP; Edkins S; Andrews JM; Buck G; Chen L; Beare D; Latimer C; Widaa S; Hinton J; Fahey C; Fu B; Swamy S; Dalgliesh GL; Teh BT; Deloukas P; Yang F; Campbell PJ; Futreal PA; Stratton MR
Nature; 2010 Feb; 463(7283):893-8. PubMed ID: 20164919
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Ikediobi ON; Davies H; Bignell G; Edkins S; Stevens C; O'Meara S; Santarius T; Avis T; Barthorpe S; Brackenbury L; Buck G; Butler A; Clements J; Cole J; Dicks E; Forbes S; Gray K; Halliday K; Harrison R; Hills K; Hinton J; Hunter C; Jenkinson A; Jones D; Kosmidou V; Lugg R; Menzies A; Mironenko T; Parker A; Perry J; Raine K; Richardson D; Shepherd R; Small A; Smith R; Solomon H; Stephens P; Teague J; Tofts C; Varian J; Webb T; West S; Widaa S; Yates A; Reinhold W; Weinstein JN; Stratton MR; Futreal PA; Wooster R
Mol Cancer Ther; 2006 Nov; 5(11):2606-12. PubMed ID: 17088437
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial.
Arnaud-Coffin P; Brahmi M; Vanacker H; Eberst L; Tredan O; Attignon V; Pissaloux D; Sohier E; Cassier P; Garin G; Pérol D; Blay JY; Dufresne A
Transl Oncol; 2020 Dec; 13(12):100870. PubMed ID: 32950930
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome-Based Treatment for Melanoma With Brain Metastasis: A Case Report.
Ayass MA; Melendez K; Griko N; Zhang J; Abi-Mosleh L
Cureus; 2024 Mar; 16(3):e56494. PubMed ID: 38638737
[TBL] [Abstract][Full Text] [Related]
13. Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers-An Overview.
Mathiyalagan R; Kariyarath Valappil A; Yang DC; Kang SC; Thambi T
Gels; 2022 Sep; 8(9):. PubMed ID: 36135270
[TBL] [Abstract][Full Text] [Related]
14. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
Farshidfar F; Rhrissorrakrai K; Levovitz C; Peng C; Knight J; Bacchiocchi A; Su J; Yin M; Sznol M; Ariyan S; Clune J; Olino K; Parida L; Nikolaus J; Zhang M; Zhao S; Wang Y; Huang G; Wan M; Li X; Cao J; Yan Q; Chen X; Newman AM; Halaban R
Nat Commun; 2022 Feb; 13(1):898. PubMed ID: 35197475
[TBL] [Abstract][Full Text] [Related]
15. The dosimetric enhancement of GRID profiles using an external collimator in pencil beam scanning proton therapy.
Smith BR; Nelson NP; Geoghegan TJ; Patwardhan KA; Hill PM; Yu J; Gutiérrez AN; Allen BG; Hyer DE
Med Phys; 2022 Apr; 49(4):2684-2698. PubMed ID: 35120278
[TBL] [Abstract][Full Text] [Related]
16. Signal pathways of melanoma and targeted therapy.
Guo W; Wang H; Li C
Signal Transduct Target Ther; 2021 Dec; 6(1):424. PubMed ID: 34924562
[TBL] [Abstract][Full Text] [Related]
17. Identification of robust reference genes for studies of gene expression in FFPE melanoma samples and melanoma cell lines.
Christensen JN; Schmidt H; Steiniche T; Madsen M
Melanoma Res; 2020 Feb; 30(1):26-38. PubMed ID: 31567589
[TBL] [Abstract][Full Text] [Related]
18. High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material.
Filia A; Droop A; Harland M; Thygesen H; Randerson-Moor J; Snowden H; Taylor C; Diaz JMS; Pozniak J; Nsengimana J; Laye J; Newton-Bishop JA; Bishop DT
Sci Rep; 2019 Jun; 9(1):8908. PubMed ID: 31222134
[TBL] [Abstract][Full Text] [Related]
19. NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
Cirenajwis H; Lauss M; Ekedahl H; Törngren T; Kvist A; Saal LH; Olsson H; Staaf J; Carneiro A; Ingvar C; Harbst K; Hayward NK; Jönsson G
Mol Oncol; 2017 Apr; 11(4):438-451. PubMed ID: 28267273
[TBL] [Abstract][Full Text] [Related]
20. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
